Physician profile
Fred Rincon
NPI 1326159443
$84,727.23
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $7,560 · 2021: $20K · 2022: $4,990 · 2023: $11K · 2024: $7,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $3,940 · Food and Beverage: $487 · Travel and Lodging: $45.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,300.00 |
| Consulting Fee | $3,940.00 |
| Food and Beverage | $486.54 |
| Travel and Lodging | $45.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $25,629.43 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $21,807.32 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $17,999.43 | 2022-2024 | Andexxa |
| C. R. Bard, INC. & Subsidiaries | $9,173.56 | 2019-2020 | |
| Medivance, INC. | $6,063.76 | 2019 | |
| Ceribell, INC. | $3,940.00 | 2024 | Pocket Eeg Device |
| Philips North America LLC | $50.56 | 2024 | (5044) Mcot |
| Ucb, INC. | $42.00 | 2019 | |
| Chiesi USA, INC. | $21.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Rincon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.